Rol de la endoscopia digestiva alta en la hipertensión portal en pacientes con cirrosis hepática compensada

Abstract

Introduction: Portal hypertension (HP) caused mainly by liver cirrhosis, which is characterized by an increase in the Hepatic Venous Pressure Gradient when this value is ≥ 6 mmHg, when this value is > 10 mmHg it becomes a clinically significant PH (CSPH) and esophageal varices develop, upper gastrointestinal endoscopy (UGE) has been used for years to diagnose and treat these varices to prevent their rupture and decompensation. Objective: To determine the usefulness of upper gastrointestinal endoscopy to know its importance in the current diagnostic and therapeutic behavior in portal hypertension caused by compensated liver cirrhosis through bibliographic research of scientific articles. Methodology: The present study is descriptive through a bibliographic review of scientific articles obtained from 2016 to the present year from academic bases such as PubMed, ScienceDirect, MESH, Scielo and clinical practice guidelines with information regarding EDA in Portal Hypertension. Conclusion: In recent years, Upper Digestive Endoscopy has been surpassed by elastography and platelet count assessment as a method of diagnosis and follow-up, and by non-selective B-blockers for the treatment of esophageal varices, however, in our country the new way of diagnosing PH is not replicable in the country, so it is suggested to maintain the UGE as diagnostic support and choose treatment with beta-blockers.